Magazine Article | July 7, 2017

CEOs 40 & Under: The Future of Pharma Innovation

By Camille Mojica Rey, Contributing Writer

To take the pulse of the biopharma industry, Life Science Leader tracked down four CEOs age 40 and under. These are the people at the forefront of innovation — something that is no easy task in a heavily regulated, patient-centered industry. Biotech is not tech. Heading up a company that is developing a pharmaceutical is a lot more challenging and riskier than starting one in your garage that is developing the next mobile phone app. If the industry is to foster innovation, however, it must make it easier for risk-taking young people to lead the way. Listed below, in alphabetical order, are four of the industry’s trailblazers.

YOU'VE REACHED THE LIMIT OF 2 FREE ARTICLES PER MONTH.
Subscribe now to continue reading
Subscribe today to continue reading this story and receive uninterrupted access to Life Science Leader online. Your subscription also includes Life Science Leader’s monthly magazine which covers key areas such as clinical research, outsourcing and pharmaceutical manufacturing.